Hospitalization Rates Among Survivors of Childhood Cancer in the Childhood Cancer Survivor Study Cohort
Overview
Oncology
Pediatrics
Authors
Affiliations
Background: Chronic health conditions are common among long-term childhood cancer survivors, but hospitalization rates have not been reported. The objective of this study was to determine overall and cause-specific hospitalization rates among survivors of childhood cancer and compare rates to the U.S. population.
Procedure: The Childhood Cancer Survivor Study (CCSS) is a retrospective cohort of 5+ year survivors of childhood malignancies treated at 26 participating centers. Self-reported hospitalizations from 10,366 survivors (diagnosed 1970-1986) were compared to U.S. population rates using age- and sex-stratified standardized incidence ratios (SIRs). Reasons for hospitalization were evaluated and associations between demographic, cancer and treatment-related risk factors with hospitalization were investigated.
Results: Survivors were, on average, 20.9 years from cancer diagnosis (SD: 4.6, range: 13-32) and 28.6 years of age (SD: 7.7, range: 13-51). Survivor hospitalization rates were 1.6 times the U.S. population (95% CI: 1.6; 1.7). Increased hospitalization rates were noted irrespective of gender, age at follow-up and cancer diagnosis, with highest SIRs noted among male (SIR = 2.6, 95% CI: 2.2; 3.0) and female (SIR = 2.7, 95% CI: 2.4; 3.1) survivors aged 45-54. Female gender, an existing chronic health condition and/or a second neoplasm, and prior treatment with radiation were associated with an increased risk of non-obstetrical hospitalization.
Conclusions: Survivors of childhood cancer demonstrate substantially higher hospitalization rates. Additional research is needed to further quantify the healthcare utilization and economic impact of treatment-related complications as this population ages.
Shu C, Mei Z, Yu B, Wang X, Wu H, Li C BMJ Public Health. 2025; 3(1):e001303.
PMID: 40017970 PMC: 11816107. DOI: 10.1136/bmjph-2024-001303.
Koskela M, Korhonen M, Haavisto A, Jahnukainen K Int J Cancer. 2024; 156(6):1236-1246.
PMID: 39497230 PMC: 11737015. DOI: 10.1002/ijc.35247.
Rajaonera D, Bejarano-Quisoboni D, Grill J, Allodji R, Pelletier-Fleury N, Journy N BMC Neurol. 2024; 24(1):335.
PMID: 39256648 PMC: 11386314. DOI: 10.1186/s12883-024-03797-8.
Disparities in pediatric cancer survivorship care: A systematic review.
Mobley E, Moke D, Milam J, Ochoa-Dominguez C, Stal J, Mitchell H Cancer Med. 2023; 12(17):18281-18305.
PMID: 37551113 PMC: 10524017. DOI: 10.1002/cam4.6426.
Regression analysis of general mixed recurrent event data.
Sun R, Sun D, Zhu L, Sun J Lifetime Data Anal. 2023; 29(4):807-822.
PMID: 37438585 PMC: 11334736. DOI: 10.1007/s10985-023-09604-9.